We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
+4.56%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.72B
AUM Growth
-$442M
(-14%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-72.14%
Top 10 Holdings %
Top 10 Hldgs %
40.29%
Holding
93
New
5
Increased
13
Reduced
23
Closed
19
Top Buys
| 1 |
argenx
ARGX
|
+$71.4M |
| 2 |
Penumbra
PEN
|
+$28.2M |
| 3 |
TRML
Tourmaline Bio
TRML
|
+$18.1M |
| 4 |
Structure Therapeutics
GPCR
|
+$16.1M |
| 5 |
Lantheus
LNTH
|
+$14M |
Top Sells
| 1 |
Boston Scientific
BSX
|
+$61.5M |
| 2 |
Natera
NTRA
|
+$44.8M |
| 3 |
MRUS
Merus
MRUS
|
+$35.7M |
| 4 |
Intuitive Surgical
ISRG
|
+$33.6M |
| 5 |
Glaukos
GKOS
|
+$30.9M |
Sector Composition
| 1 | Healthcare | 48.6% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$17.3B
| $94.2M | 3.46% |
715,209
-252,815
| -26% | -$29.1M |
|
2
Vaxcyte
PCVX
$8.19B
| $81M | 2.98% |
1,289,965
-329,588
| -20% | -$17.1M |
|
3
Xenon Pharmaceuticals
XENE
$6.55B
| $75.9M | 2.79% |
1,647,311
-456,085
| -22% | -$16.1M |
|
|
DAWN
4
DELISTED
Day One Biopharmaceuticals
DAWN
| $61.5M | 2.26% |
4,215,573
+500,000
| +13% | +$6.06M |
|
5
iRhythm Holdings
IRTC
$3.72B
| $60.8M | 2.23% |
568,157
| – | – |
|
|
6
argenx
ARGX
$54B
| $58.3M | 2.14% |
+153,204
| New | +$71.4M |
|
|
7
Penumbra
PEN
$12.5B
| $56M | 2.06% |
222,792
+127,477
| +134% | +$28.2M |
|
8
Keros Therapeutics
KROS
$218M
| $44.5M | 1.63% |
1,118,961
-238,348
| -18% | -$7.47M |
|
|
FNA
9
DELISTED
Paragon 28, Inc.
FNA
| $41.8M | 1.53% |
3,361,824
| – | – |
|
10
Immunocore
IMCR
$1.76B
| $41.8M | 1.53% |
611,365
-295,608
| -33% | -$15.4M |
|
11
Thermo Fisher Scientific
TMO
$199B
| $40.2M | 1.48% |
75,749
| – | – |
|
12
Align Technology
ALGN
$13B
| $40.1M | 1.47% |
146,313
+21,100
| +17% | +$5M |
|
|
NVRO
13
DELISTED
NEVRO CORP.
NVRO
| $38.2M | 1.4% |
1,776,368
| – | – |
|
14
Inspire Medical Systems
INSP
$1.46B
| $37.6M | 1.38% |
184,658
+84,358
| +84% | +$13.7M |
|
15
OrthoPediatrics
KIDS
$507M
| $36M | 1.32% |
1,107,770
+50,000
| +5% | +$1.45M |
|
16
BioCryst Pharmaceuticals
BCRX
$2.39B
| $34.3M | 1.26% |
5,718,477
+355,497
| +7% | +$2.06M |
|
17
Legend Biotech
LEGN
$4.46B
| $33.9M | 1.24% |
562,600
-316,964
| -36% | -$20.1M |
|
18
Maravai LifeSciences
MRVI
$1.04B
| $33M | 1.21% |
5,040,635
+1,065,778
| +27% | +$6.89M |
|
|
19
Lantheus
LNTH
$6.79B
| $30.7M | 1.13% |
495,100
+206,800
| +72% | +$14M |
|
20
Alector
ALEC
$167M
| $26.5M | 0.97% |
3,324,308
-749,812
| -18% | -$4.44M |
|
21
Krystal Biotech
KRYS
$10.3B
| $24.3M | 0.89% |
196,200
+118,703
| +153% | +$13.2M |
|
|
TRML
22
DELISTED
Tourmaline Bio
TRML
| $23.7M | 0.87% |
+906,820
| New | +$18.1M |
|
23
Guardant Health
GH
$21.6B
| $20.5M | 0.75% |
758,928
+69,928
| +10% | +$1.83M |
|
|
24
Glaukos
GKOS
$9.21B
| $19.3M | 0.71% |
242,760
-453,032
| -65% | -$30.9M |
|
25
Apogee Therapeutics
APGE
$10.2B
| $19M | 0.7% |
681,101
+189,988
| +39% | +$3.81M |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM